Somaxon Pharmaceuticals Report issue

For profit Phase 3
Founded: Solana Beach CA United States (2003)
Status: Acquired by Pernix (2013)

Organization Overview

First Clinical Trial
2005
NCT00132119
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Somaxon Pharmaceuticals CMO

Active Ingredients

Drugs in Phase 3 Trials (1)

nalmefene (revex) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Gambling (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1